The National Agency for Food and Drug Administration and Control (NAFDAC) has been informed that the Singapore Health Science Authority (HSA) on 20th June, 2017 issued a recall of all unexpired lots of Nitroglycerin injection manufactured by Advanced Pharma, Inc. d/b/a Avella of Houston, USA.
The recall was due to a laboratory test result which indicated a lower than expected potency on certain lots of compounded Nitroglycerin injection which may lead to a lower dose being administered which can result to risk of serious health complications.
Nitroglycerine is used to control high blood pressure, congestive heart failure, lung congestion and chest pain especially in heart attack patients. It decreases the workload on the heart by enlarging (dilating) blood vessels
Product Name: Nitoglycerin Injection
Lot Number: All unexpired lots
Manufacturing Dates: 3rd March and 31st May 2017
Manufacturer: Advanced Pharma, Inc. d/b/a Avella of Houston USA.
Healthcare Provider Action
- Healthcare providers in possession of these affected products should stop using them and in return unused portions to the nearest NAFDAC office.
- Report adverse events relating to use of these medicines to NAFDAC PRASCOR (20543-Toll free from all networks) or via firstname.lastname@example.org
NOW YOU CAN BE THE REPORTER: Submit your story, news reports, articles, pictures, events and press release to us via Watsapp/ Telegram (08105233399) or Email (email@example.com) | Follow us on Twitter @Medicalworld